Neurim Pharmaceuticals Ltd.
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Private
- Established
- 1991-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.neurim.com
A Study of the Efficacy of Prolonged-Release Melatonin Versus Placebo in Diabetic Patients Suffering From Insomnia
- First Posted Date
- 2009-03-25
- Last Posted Date
- 2009-05-01
- Lead Sponsor
- Neurim Pharmaceuticals Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT00869128
Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs
- First Posted Date
- 2009-01-05
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Neurim Pharmaceuticals Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT00816673
- Locations
- 🇫🇷
FORENAP, Centre Hospitalier De Rouffach, France
Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia
- First Posted Date
- 2008-02-05
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Neurim Pharmaceuticals Ltd.
- Target Recruit Count
- 8
- Registration Number
- NCT00607451
- Locations
- 🇮🇱
Neurim Pharmaceuticals Ltd., Tel-Aviv, Israel
Efficacy and Safety of Circadin® 2 mg in the Treatment of Primary Insomnia Patients
- First Posted Date
- 2006-11-08
- Last Posted Date
- 2018-05-01
- Lead Sponsor
- Neurim Pharmaceuticals Ltd.
- Target Recruit Count
- 930
- Registration Number
- NCT00397189
- Locations
- 🇬🇧
CPS Research, Glasgow, United Kingdom
© Copyright 2024. All Rights Reserved by MedPath